Table 3.

Effect of Lycopene treatment on gastric SOD, CAT, GSH-Px activities and MDA level in gastric cancer rats.

Group	SOD (U/mg)	CAT (U/mg)	GSH-Px (U/mg)	MDA (U/mg)
I	200.14 ± 27.31	38.12 ± 4.42	27.29 ± 3.28	6.39 ± 0.72
II	117.32 ± 14.21b	21.72 ± 3.17b	20.13 ± 2.41b	9.31 ± 1.32b
III	152.71 ± 17.08d	26.92 ± 3.05d	23.81 ± 2.64c	8.14 ± 0.93c
IV	170.48 ± 19.36d	29.33 ± 3.14d	26.18 ± 2.91d	7.53 ± 0.84d
V	194.28 ± 22.13d	37.11 ± 4.25d	29.52 ± 3.28d	6.54 ± 0.74d

Values are given as Mean ± SD for groups of eight rats each.

^bp < 0.05, gastric cancer model rats (group II) were compared with normal control (group I);

^cp < 0.05,

^dp < 0.01, lycopene treated rats (group III, IV and V) were compared with gastric cancer model control (group II).